Anuncia announced today that it received FDA breakthrough device designation for its ReFlow system for cerebral spinal fluid (CSF) management. Lowell, Mass.-based Anuncia’s ReFlow Mini is intended to treat CSF disorders requiring shunting, including hydrocephalus, according to a news release. It has been optimized to serve a broad hydrocephalus population, including infants with non-communicating hydrocephalus, […]
Spine
ReWalk Robotics closes $40M private placement
ReWalk Robotics (NSDQ:RWLK) announced today that it closed a private placement worth approximately $40 million. Marlborough, Mass.-based Rewalk Robotics’ private placement included more than 10.9 million ordinary shares and warrants to purchase up to nearly 5.5 million ordinary shares at a purchase price of $3.6625 per share and associated warrant, according to a news release. […]
NuVasive reports mixed Q4 results
NuVasive (NASDAQ: NUVA) today reported Q4 earnings that beat the consensus forecast on Wall Street, but it came up short on revenue. The San Diego–based spine tech company earned $1.7 million, or 3¢ per share, on sales of $291.8 million for the three months ended Dec. 31, 2020, for a bottom-line drop of –94% on […]
Nexus Spine launches spinal implants
Nexus Spine today launched its PressOn patient-specific fixation system for stabilizing the human spine and its Tranquil flexible titanium device for interbody fusion. The Tranquil and PressOn implants feature compliant mechanism technology to allow for well-established biocompatible materials like titanium to behave like organic human tissue on a microscopic level. The technology allows for bio-friendly […]
ReWalk Robotics misses on revenues in Q4
ReWalk Robotics (NSDQ:RWLK) shares dipped pre-market today on fourth-quarter results that couldn’t top the consensus forecast. The Marlborough, Mass.-based robotic exoskeleton device maker posted losses of -$2.9 million, or -14¢ per share, on sales of $1.2 million for the three months ended Dec. 31, 2020, for a 17.6% bottom-line gain on sales growth of 3.1%. Adjusted […]
Former Medtronic exec to lead Zimmer Biomet spinoff
Zimmer Biomet (NYSE:ZBH) announced today that Vafa Jamali will serve as the CEO of “NewCo,” the spine and dental business spinoff that Zimmer Biomet expects to close in mid-2022. A more than 25-year medtech veteran, Jamali most recently served as chief commercial officer of Rockley Photonics. Before that, he was SVP and president of Respiratory, Gastrointestinal […]
DTW Podcast: Zimmer Biomet slims, Corza Medical grows in pursuit of grabbing market share
In this week’s DeviceTalks Weekly Podcast, Rich Newitter, managing director at SVB Leerink, says Zimmer Biomet’s decision to spin out its spinal and dental business will accelerate its already impressive market share grab in its core orthopedics industry. Newitter says CEO Bryan Hanson brings a tried-and-true diversification model used by companies like his former employer, […]
BREAKING: Zimmer Biomet to spin off spine and dental businesses
Zimmer Biomet (NYSE:ZBH) — one of the world’s largest orthopedic device companies — will be a bit smaller going forward. The Warsaw, Ind.–based company announced today that it will spin off its spine and dental businesses into a new, independent, publicly-traded company called NewCo. Zimmer Biomet plans to complete the transaction by mid-2022. The businesses that […]
Laura Francis to move up to CEO spot at Si-Bone
Si-Bone (NSDQ:SIBN) will promote its present CFO and COO Laura Francis into the corner office of the company, which makes the iFuse implant for treating lower back pain. Francis will become CEO once the company finds a new CFO or May 1 — whatever comes first. Present CEO Jeff Dunn will stay with the company as […]
Alphatec raises $30M
Alphatec (NSDQ:ATEC) filed an SEC Form D to confirm the sale of $30 million in an equity offering worth nearly $170 million. The new notice offering of equity, which made its first sale on Dec. 18, 2020, has received investments from six participants so far. The company does not intend for the offering of about $168 […]
Two former Boston Scientific execs join spine device maker Omnia Medical
Former Boston Scientific (NYSE:BSX) executives Jennifer Martin and Dan Rogers have joined orthopedic implant maker Omnia Medical. Martin, who most recently served as senior director of customer engagement at Boston Scientific, will be the president of Omnia Medical’s new interventional pain therapies division, according to a news release. Rogers joins as VP of sales for the […]
